Research programme: radioligand therapeutics - ARTBIO/FogPharma
Alternative Names: HEARTs; Helicon-enabled ARTs - ARTBIO/FogPharmaLatest Information Update: 21 May 2024
At a glance
- Originator ARTBIO; FogPharma
- Class Antineoplastics; Lead radioisotopes; Peptides; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer